EQS-News: CompuGroup Medical SE & Co. KGaA
/ Key word(s): Miscellaneous
100 million e-prescriptions issued in CGM's German practice software systems Koblenz - 100 million e-prescriptions have been issued in the German ambulatory information systems supplied by CompuGroup Medical (CGM). CGM is thus the first practice software provider to exceed this mark. More than 32 percent of all e-prescriptions generated in German medical practices are processed via CGM's systems. “100 million e-prescriptions via CGM systems speaks for itself: CGM processes by far the highest number of e-prescriptions in Germany in its ambulatory information systems. We thus guarantee the practical usability of a central application in the digitized healthcare system. This corresponds to our core understanding as a reliable partner at the side of doctors and their practice teams”, says Dr. Ulrich Thomé, Managing Director Ambulatory Information Systems DACH at CGM. “In recent months, CGM has also significantly optimized the availability of service and support for its ambulatory information systems in Germany. 80 percent of our customers receive qualified support on the phone in less than 30 seconds”, Dr. Thomé continues. CGM also offers free training courses for doctors, medical assistants (German acronym: MFA) and trainees, which are in great demand. At the so-called MFA Days, CGM provided 1,200 participants with in-depth knowledge about the practice software and presented new functions in four half-day training sessions. e-prescription has become the standard in Germany: According to gematik, a total of over 280 million e-prescriptions have now been redeemed. At peak times, up to 2.4 million digital prescriptions are issued every day, according to gematik. More than 84,000 medical facilities issue e-prescriptions and over 17,000 pharmacies redeem e-prescriptions.
17.07.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | CompuGroup Medical SE & Co. KGaA |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Phone: | +49 (0)160 3630362 |
Fax: | +49 (0)261 8000 3200 |
E-mail: | investor@cgm.com |
Internet: | www.cgm.com |
ISIN: | DE000A288904 |
WKN: | A28890 |
Indices: | SDAX, TecDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1947907 |
End of News | EQS News Service |
|
1947907 17.07.2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.